Physician profile
Alipi Bonm
NPI 1699137570
$17,238.18
in general payments reported to CMS, 2019-2025
12 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.00 · 2023: $84.40 · 2024: $5,827 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,433 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,163 · Travel and Lodging: $2,474 · Food and Beverage: $1,131 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,432.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,162.50 |
| Travel and Lodging | $2,474.00 |
| Food and Beverage | $1,131.09 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $12,834.89 | 2024-2025 | Gomekli |
| Alexion Pharmaceuticals, INC. | $2,661.37 | 2024-2025 | Koselugo |
| Servier Pharmaceuticals LLC | $1,038.83 | 2025 | |
| Novocure INC. | $211.30 | 2024-2025 | Optune |
| Integra Lifesciences Corporation | $156.26 | 2025 | Codman Certas, Duraseal Exact Spinal Sealant System, Codman Hakim |
| Merck Sharp & Dohme LLC | $143.09 | 2024 | Welireg |
| Monteris Medical Corporation | $84.40 | 2023 | Neuroblate |
| Teva Pharmaceuticals USA, INC. | $40.09 | 2025 | Ajovy |
| Novartis Pharmaceuticals Corporation | $31.29 | 2024 | |
| Gt Medical Technologies, INC | $20.00 | 2021 | |
| Tempus Ai, INC | $16.66 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alipi Bonm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.